Kundu Chittaranjan, Shukla V D, Santwani M A, Bhatt N N
Senior A. Medical Officer, Govt. of West Bengal, Ravindra Nagar, Stadium road, Mignapur-721101, West Bengal, India.
Ayu. 2010 Oct;31(4):436-41. doi: 10.4103/0974-8520.82035.
This clinical trial was conducted to evaluate the efficacy of Shirodhara and that of Sarpagandha Vati in essential hypertension. A total 47 patients were selected for study, out of which 40 patients (20 in each group) completed the course of treatment. Study subjects were randomly allotted into two groups, with one group being treated with Shirodhara and the other with Sarpagandha Vati. Specialized Ayurvedic rating scales like Manasa Pariksha Bhava as well as the Hamilton Anxiety Rating Scale were adopted to assess the effect of therapy. The effects of treatment on the chief complaints and the associated complaints were also evaluated. The results in the Shirodhara group were better than that in the Sarpagandha group. Although both Sarpagandha Vati and Shirodhara helped in reducing systolic and diastolic pressures, the effect of Shirodhara was more marked.
本临床试验旨在评估希罗达拉疗法和蛇根碱片治疗原发性高血压的疗效。共选取47例患者进行研究，其中40例患者（每组20例）完成了治疗疗程。研究对象被随机分为两组，一组接受希罗达拉疗法治疗，另一组接受蛇根碱片治疗。采用专业的阿育吠陀评定量表如“心理检查状态”以及汉密尔顿焦虑评定量表来评估治疗效果。还评估了治疗对主要症状和相关症状的影响。希罗达拉组的结果优于蛇根碱片组。虽然蛇根碱片和希罗达拉疗法都有助于降低收缩压和舒张压，但希罗达拉疗法的效果更为显著。
